Modra Pharmaceuticals Announces U.S. Patent Issuance for Mod

Modra Pharmaceuticals ("Modra") today announced that the U.S. Patent and Trademark Office (USPTO) has issued to Modra U.S. Patent No. 11,571,408, covering the use of its oral taxane therapeutic ModraDoc006/r.

Related Keywords

, Dennis Riedl , Colin Freund , Desmond James , Trademark Office , Modra Pharmaceuticals , Trophic Communications , Castration Resistant Prostate Cancer , Modra , Pharmaceuticals , Nnounces , Patent , Issuance , Odradoc006 ,